Friday, January 30, 2015

Valeant to buy Dendreon's prostate cancer vaccine Provenge

… the worldwide rights to its cancer vaccine, Provenge, and certain assets … immune system to attack advanced prostate cancer cells, was hindered by its …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)